Valuation: SMS Pharmaceuticals Limited

Market Cap 35.11B 367M 314M 294M 269M 505M 512M 3.47B 1.35B 17.64B 1.38B 1.35B 58.33B P/E 2024
30.3x
P/E 2025 27.3x
Enterprise Value 37.8B 395M 338M 317M 290M 544M 551M 3.74B 1.46B 18.99B 1.48B 1.45B 62.8B EV / Sales 2024
2.47x
EV / Sales 2025 2.75x
Free-Float
23.47%
Yield 2024
0.22%
Yield 2025 0.19%
1 day+0.03%
1 week-1.31%
Current month-4.63%
1 month-8.14%
3 months-16.26%
6 months-4.26%
Current year+14.88%
1 week 351
Extreme 351
364.3
1 month 351
Extreme 351
399.95
Current year 293.15
Extreme 293.15
447.8
1 year 221.02
Extreme 221.02
447.8
3 years 111.85
Extreme 111.85
447.8
5 years 54.55
Extreme 54.55
447.8
10 years 24
Extreme 24
447.8
Manager TitleAgeSince
Chief Executive Officer 66 30/08/1990
Director of Finance/CFO - 13/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 30/08/1990
Director/Board Member 38 05/06/2020
Director/Board Member 48 29/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%-1.31%+48.07%+182.23% 349M
-0.08%-1.43%+15.99%+67.26% 47.71B
-3.21%+1.37%+52.36%+125.75% 40.3B
-0.40%-1.23%-10.08%+16.08% 12.09B
+1.11%-1.34%+13.61%+71.49% 11.68B
0.00%+0.58%+30.65%+148.80% 9.19B
-0.39%-0.92%+19.81%+39.54% 7.57B
-1.35%+0.74%+47.03%-11.93% 7.24B
-0.64%-0.02%+19.42%+199.06% 6.84B
-5.36%-6.36%-36.28%+18.28% 5.42B
Average -1.03%-1.13%+20.06%+85.66% 14.84B
Weighted average by Cap. -1.15%-0.57%+24.50%+83.64%

Financials

2024 2025
Net sales 7.09B 74.13M 63.5M 59.41M 54.39M 102M 103M 702M 274M 3.56B 278M 272M 11.78B 7.83B 81.81M 70.08M 65.57M 60.02M 113M 114M 775M 302M 3.93B 307M 301M 13.01B
Net income 498M 5.21M 4.46M 4.17M 3.82M 7.17M 7.27M 49.31M 19.23M 250M 19.55M 19.13M 828M 691M 7.23M 6.19M 5.79M 5.3M 9.95M 10.08M 68.42M 26.68M 347M 27.13M 26.54M 1.15B
Net Debt 2.45B 25.57M 21.9M 20.49M 18.76M 35.21M 35.67M 242M 94.43M 1.23B 96.01M 93.92M 4.07B 2.69B 28.14M 24.11M 22.56M 20.65M 38.75M 39.26M 266M 104M 1.35B 106M 103M 4.47B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,470
Date Price Change Volume
21/08/26 INR 356.60 +0.03% 130,248
20/08/26 INR 356.50 +0.13% 111,900
19/08/26 INR 356.05 -0.92% 103,007
18/08/26 INR 359.35 +0.35% 126,543
17/08/26 INR 358.10 -0.90% 132,263

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock